Teza Capital Management LLC United Therapeutics Corp Transaction History

Teza Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Feb 22, 2024	SELL	$211.82 - $248.24 $26,053 - $30,533	-123 Reduced 10.7%	1,027 $231,000
Q3 2023 Nov 14, 2023	SELL	$211.82 - $248.24 $66,723 - $78,195	-315 Reduced 16.9%	1,549 $349,000
Q2 2023 Feb 22, 2024	BUY	$205.19 - $232.99 $235,968 - $267,938	1,150 New	1,150 $253,000
Q2 2023 Aug 14, 2023	BUY	$205.19 - $232.99 $382,474 - $434,293	1,864 New	1,864 $411,000
Q3 2020 Nov 12, 2020	SELL	$99.9 - $121.13 $1.24 Million - $1.5 Million	-12,379 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$92.74 - $125.82 $1.15 Million - $1.56 Million	12,379 New	12,379 $1.5 Million
Q3 2018 Nov 14, 2018	SELL	$113.81 - $129.46 $313,091 - $356,144	-2,751 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$101.14 - $118.31 $268,526 - $314,113	-2,655 Reduced 49.11%	2,751 $311,000
Q1 2018 May 11, 2018	BUY	$107.21 - $151.94 $236,505 - $335,179	2,206 Added 68.94%	5,406 $607,000
Q4 2017 Feb 14, 2018	BUY	$118.58 - $151.28 $379,456 - $484,096	3,200	3,200 $473,000

676

42.1M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.9B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Teza Capital Management LLC with notifications on news.